187 related articles for article (PubMed ID: 16277229)
1. [Biomarker and imaging of Alzheimer's disease].
Kawarabayashi T; Shoji M
No To Shinkei; 2005 Oct; 57(10):839-52. PubMed ID: 16277229
[No Abstract] [Full Text] [Related]
2. [Markers of prodromal Alzheimer's disease].
de Souza LC; Sarazin M; Uspenskaya O; Habert MO; Lamari F; Lehéricy S; Dubois B
Rev Neurol (Paris); 2012 Nov; 168(11):815-24. PubMed ID: 22944619
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers reflecting different facets of Alzheimer's disease.
Zetterberg H
Eur J Neurol; 2008 Nov; 15(11):1143-4. PubMed ID: 18973609
[No Abstract] [Full Text] [Related]
4. Analytical challenges related to the use of biomarker ratios for the biological diagnosis of Alzheimer's disease.
Lehmann S; Delaby C; Paquet C; Gabelle A
Clin Chem Lab Med; 2015 Jul; 53(8):e175-7. PubMed ID: 25870963
[No Abstract] [Full Text] [Related]
5. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.
Prvulovic D; Hampel H
Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022
[TBL] [Abstract][Full Text] [Related]
6. The utility of the new research diagnostic criteria for Alzheimer's disease.
Dubois B; Gauthier S; Cummings J
Int Psychogeriatr; 2013 Feb; 25(2):175-7. PubMed ID: 23148941
[No Abstract] [Full Text] [Related]
7. Alzheimer's: forestalling the darkness.
Stix G
Sci Am; 2010 Jun; 302(6):50-7. PubMed ID: 20521480
[No Abstract] [Full Text] [Related]
8. Amyloid beta pathology in Alzheimer's disease and schizophrenia.
Religa D; Laudon H; Styczynska M; Winblad B; Näslund J; Haroutunian V
Am J Psychiatry; 2003 May; 160(5):867-72. PubMed ID: 12727689
[TBL] [Abstract][Full Text] [Related]
9. Role of amyloid β1-42 and neuroimaging biomarkers in Alzheimer's disease.
Lista S; Emanuele E
Biomark Med; 2011 Aug; 5(4):411-3. PubMed ID: 21861661
[No Abstract] [Full Text] [Related]
10. Beyond diagnosis: what biomarkers are teaching us about the "bio"logy of Alzheimer disease.
Rabinovici GD; Roberson ED
Ann Neurol; 2010 Mar; 67(3):283-5. PubMed ID: 20373338
[No Abstract] [Full Text] [Related]
11. Biomarkers, assays, and therapies for Alzheimer disease.
Beriault DR; Diamandis EP; Portelius E; Perret-Liaudet A; Salloway S
Clin Chem; 2015 Jul; 61(7):903-8. PubMed ID: 26015517
[No Abstract] [Full Text] [Related]
12. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
Shea YF; Ha J; Chu LW
Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
[TBL] [Abstract][Full Text] [Related]
13. CSF levels of beta-amyloid 1-42, tau and phosphorylated tau protein in CADASIL.
Formichi P; Parnetti L; Radi E; Cevenini G; Dotti MT; Federico A
Eur J Neurol; 2008 Nov; 15(11):1252-5. PubMed ID: 18803653
[TBL] [Abstract][Full Text] [Related]
14. The role of biomarkers in clinical trials for Alzheimer disease.
Thal LJ; Kantarci K; Reiman EM; Klunk WE; Weiner MW; Zetterberg H; Galasko D; Praticò D; Griffin S; Schenk D; Siemers E
Alzheimer Dis Assoc Disord; 2006; 20(1):6-15. PubMed ID: 16493230
[TBL] [Abstract][Full Text] [Related]
15. 18F-barbiturates are PET tracers with diagnostic potential in Alzheimer's disease.
Calamai E; Dall'Angelo S; Koss D; Domarkas J; McCarthy TJ; Mingarelli M; Riedel G; Schweiger LF; Welch A; Platt B; Zanda M
Chem Commun (Camb); 2013 Jan; 49(8):792-4. PubMed ID: 23235438
[TBL] [Abstract][Full Text] [Related]
16. Genetic and biochemical markers for Alzheimer's disease: recent developments.
Mulder C; Scheltens P; Visser JJ; van Kamp GJ; Schutgens RB
Ann Clin Biochem; 2000 Sep; 37 ( Pt 5)():593-607. PubMed ID: 11026514
[No Abstract] [Full Text] [Related]
17. Alzheimer's disease is getting easier to spot.
Dolgin E
Nature; 2018 Jul; 559(7715):S10-S12. PubMed ID: 30046081
[No Abstract] [Full Text] [Related]
18. [Recent study on Alzheimer's disease].
Hirai S
Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):367-71. PubMed ID: 8315330
[No Abstract] [Full Text] [Related]
19. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease.
Thordardottir S; Ståhlbom AK; Ferreira D; Almkvist O; Westman E; Zetterberg H; Eriksdotter M; Blennow K; Graff C
J Alzheimers Dis; 2015; 43(4):1393-402. PubMed ID: 25182737
[TBL] [Abstract][Full Text] [Related]
20. [Brain imaging of Alzheimer' disease: state of the art and perspectives for clinicians].
Trombella S; Assal F; Zekry D; Gold G; Giannakopoulos P; Garibotto V; Démonet JF; Frisoni GB
Rev Med Suisse; 2016 Apr; 12(515):795-8. PubMed ID: 27276723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
